Compile Data Set for Download or QSAR
Report error Found 86 Enz. Inhib. hit(s) with all data for entry = 50014618
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145270({4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[e]...)
Affinity DataIC50: 1nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145252(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 2nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145282(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 2nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145289({4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[e]...)
Affinity DataIC50: 2nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145266(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 2nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145277(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 2nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145279(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 2nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145235({4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[e]...)
Affinity DataIC50: 2nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145244({4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[e]...)
Affinity DataIC50: 2nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145280(Cyclopropyl-{4-[(9-fluoro-5,6-dihydro-4H-3-thia-1-...)
Affinity DataIC50: 2nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Rat)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145232({4-[(9-Methyl-4,5-dihydro-6-oxa-3-thia-1-aza-benzo...)
Affinity DataIC50: 2.90nMAssay Description:In vitro binding affinity against rat neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089060(Naphthalene-1-sulfonic acid [4-(4-amino-quinazolin...)
Affinity DataIC50: 3nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145256(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 3nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145243(N,N-dimethyl-N'-({4-[(19-Fluoro-2-methyl-4,5-dihyd...)
Affinity DataIC50: 3nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145272(2-(Cyclopropylmethyl-methyl-amino)-1-{4-[(9-fluoro...)
Affinity DataIC50: 3nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145241((R)-5-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-be...)
Affinity DataIC50: 4nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145267(4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[e]a...)
Affinity DataIC50: 4nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145295(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 4nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145259(2-Dimethylamino-1-{4-[(9-fluoro-5,6-dihydro-4H-3-t...)
Affinity DataIC50: 4nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145293(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 5nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145287({4-[(9-Fluoro-4,5-dihydro-6-oxa-3-thia-1-aza-benzo...)
Affinity DataIC50: 5nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145232({4-[(9-Methyl-4,5-dihydro-6-oxa-3-thia-1-aza-benzo...)
Affinity DataIC50: 5nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145242(2-Methyl-1-{4-[(9-methyl-4,5-dihydro-6-oxa-3-thia-...)
Affinity DataIC50: 5nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145275(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 6nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Rat)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145236(1-{4-[(9-Fluoro-4,5-dihydro-6-oxa-3-thia-1-aza-ben...)
Affinity DataIC50: 6nMAssay Description:In vitro binding affinity against rat neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145261(2-Cyclopropyl-N-{4-[(9-fluoro-5,6-dihydro-4H-3-thi...)
Affinity DataIC50: 6nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145254(Pentanoic acid {4-[(9-fluoro-5,6-dihydro-4H-3-thia...)
Affinity DataIC50: 6nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145283(1-{4-[(5,6-Dihydro-4H-3-thia-1-aza-benzo[e]azulen-...)
Affinity DataIC50: 6nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145238(2-(Cyclopropylmethyl-amino)-1-{4-[(9-fluoro-5,6-di...)
Affinity DataIC50: 6nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145246(Cyclopropanecarboxylic acid {4-[(9-fluoro-5,6-dihy...)
Affinity DataIC50: 6nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145297(N-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 6nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145236(1-{4-[(9-Fluoro-4,5-dihydro-6-oxa-3-thia-1-aza-ben...)
Affinity DataIC50: 7nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145285(1-{4-[(9-Methyl-4,5-dihydro-6-oxa-3-thia-1-aza-ben...)
Affinity DataIC50: 7nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145233(1-{4-[(9-Chloro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 7nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145294(1-{4-[(9-Chloro-8-fluoro-4,5-dihydro-6-oxa-3-thia-...)
Affinity DataIC50: 13nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145248(Thiophene-2-carboxylic acid {4-[(9-fluoro-5,6-dihy...)
Affinity DataIC50: 15nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145263(N,N-dimethyl-N'-({4-[(1,8-Dithia-3-aza-dibenzo[e,h...)
Affinity DataIC50: 15nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145264(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 15nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145292(2-(4-Acetyl-4-phenyl-cyclohexyl)-N-(9-fluoro-5,6-d...)
Affinity DataIC50: 15nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145249(1-{4-[(9-Methoxy-4,5-dihydro-6-oxa-3-thia-1-aza-be...)
Affinity DataIC50: 17nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145286({4-[(9-Methyl-4,5-dihydro-6-oxa-3-thia-1-aza-benzo...)
Affinity DataIC50: 17nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145291(2-Ethoxy-1-{4-[(9-methyl-4,5-dihydro-6-oxa-3-thia-...)
Affinity DataIC50: 18nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145298(2-(Cyclopropylmethyl-methyl-amino)-1-{4-[(9-fluoro...)
Affinity DataIC50: 18nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145250({4-[(9-Fluoro-4,5-dihydro-6-oxa-3-thia-1-aza-benzo...)
Affinity DataIC50: 19nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145276(1-{4-[(9-Chloro-8-fluoro-4,5-dihydro-6-oxa-3-thia-...)
Affinity DataIC50: 20nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145271({4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[e]...)
Affinity DataIC50: 20nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145257(2-Isopropoxy-1-{4-[(9-methyl-4,5-dihydro-6-oxa-3-t...)
Affinity DataIC50: 21nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145290(1-{4-[(9-Fluoro-4,5-dihydro-6-oxa-3-thia-1-aza-ben...)
Affinity DataIC50: 22nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145265(N-{4-[4-(4-Fluoro-phenyl)-thiazol-2-ylamino]-cyclo...)
Affinity DataIC50: 23nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50145296(1-{4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[...)
Affinity DataIC50: 24nMAssay Description:In vitro binding affinity against human neuropeptide Y5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 86 total ) | Next | Last >>
Jump to: